Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiping He

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.
Cancer Research|May 2, 2019
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine StarvationLandon J Hansen, Ran Sun, Rui Yang, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalPatrick J Killela, Zachary J Reitman, Yuchen Jiao, et al.
Science (New York, N.Y.)|December 18, 2010
The genetic landscape of the childhood cancer medulloblastomaD Williams Parsons, Meng Li, Xiaosong Zhang, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.
Cancer Research|May 2, 2019
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine StarvationLandon J Hansen, Ran Sun, Rui Yang, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalPatrick J Killela, Zachary J Reitman, Yuchen Jiao, et al.
Science (New York, N.Y.)|December 18, 2010
The genetic landscape of the childhood cancer medulloblastomaD Williams Parsons, Meng Li, Xiaosong Zhang, et al.
Pageof 15